Similarly, high expression of PD-L1 by M1 macrophages that were located near both CD8+ T cells and the tumour-stroma boundary has been correlated with increased likelihood of response of metastatic melanoma to ICB therapy (66). The gene discussed is CD8A; the disease is neoplasm.